Characterization of the 13-cis-retinoic acid/cyclodextrin inclusion complexes by phase solubility, photostability, physicochemical and computational analysis.

[1]  T. Higuchi,et al.  Phase solubility techniques , 1965 .

[2]  M. Sporn,et al.  Inhibitory effect of 13-cis-retinoic acid on urinary bladder carcinogenesis induced in C57BL/6 mice by N-butyl-N-(4-hydroxybutyl)-nitrosamine. , 1978, Cancer research.

[3]  W. Hong,et al.  13-cis-retinoic acid in the treatment of oral leukoplakia. , 1986, The New England journal of medicine.

[4]  N. Bodor,et al.  Effect of various cyclodextrins on solution stability and dissolution rate of doxorubicin hydrochloride , 1992 .

[5]  W. Bollag.  Experimental basis of cancer combination chemotherapy with retinoids, cytokines, 1,25‐dihydroxyvitamin D3, and analogs , 1994, Journal of cellular biochemistry.

[6]  P. Mura,et al.  Interaction between naproxen and chemically modified β-cyclodextrins in the liquid and solid state , 1995 .

[7]  J. Mulshine,et al.  Analysis of small cell lung cancer cell growth inhibition by 13-cis-retinoic acid: importance of bioavailability. , 1995, Cell growth & differentiation : the molecular biology journal of the American Association for Cancer Research.

[8]  G. Bruni,et al.  Thermoanalytical and spectroscopic characterization ofβ-cyclodextrin/ketoprofen inclusion complexes , 1995 .

[9]  V. Stella,et al.  Pharmaceutical applications of cyclodextrins. 2. In vivo drug delivery. , 1996, Journal of pharmaceutical sciences.

[10]  M. Brewster,et al.  Pharmaceutical applications of cyclodextrins. 1. Drug solubilization and stabilization. , 1996, Journal of pharmaceutical sciences.

[11]  K K Matthay,et al.  Treatment of High-Risk Neuroblastoma with Intensive Chemotherapy, Radiotherapy, Autologous Bone Marrow Transplantation, and 13-cis-Retinoic Acid , 1999 .

[12]  R. Niles,et al.  Recent advances in the use of vitamin A (retinoids) in the prevention and treatment of cancer. , 2000, Nutrition.

[13]  J. Mulshine,et al.  Topical delivery of 13-cis-retinoic acid by inhalation up-regulates expression of rodent lung but not liver retinoic acid receptors. , 2000, Clinical cancer research : an official journal of the American Association for Cancer Research.

[14]  J. Mulshine,et al.  Inhaled isotretinoin (13-cis retinoic acid) is an effective lung cancer chemopreventive agent in A/J mice at low doses: a pilot study. , 2000, Clinical cancer research : an official journal of the American Association for Cancer Research.

[15]  Chan,et al.  2‐Hydroxypropyl‐β‐cyclodextrin increases aqueous solubility and photostability of all‐trans‐retinoic acid , 2000 .

[16]  P. Ho,et al.  Kinetic study of a 2-hydroxypropyl-beta-cyclodextrin-based formulation of all-trans-retinoic acid in Sprague-Dawley rats after oral or intravenous administration. , 2000, Journal of pharmaceutical sciences.

[17]  M. Brewster,et al.  Alfaxalone: Effect of Temperature on Complexation with 2-Hydroxypropyl-β-cyclodextrin , 2002 .

[18]  S. Chan,et al.  Inclusion of acitretin into cyclodextrins: phase solubility, photostability, and physicochemical characterization. , 2003, Journal of pharmaceutical sciences.

[19]  Jinming Gao,et al.  Enhancement of Solubility and Bioavailability of β-Lapachone Using Cyclodextrin Inclusion Complexes , 2003, Pharmaceutical Research.

[20]  S. Chan,et al.  Biopharmaceutics of β-cyclodextrin derivative-based formulations of acitretin in sprague-dawley rats , 2004 .